SCHMC

검색

SCHMC Repository 진료부 종양혈액내과 2. Conference Papers

Browsing "2. Conference Papers" by 제목 :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 28건 중 1-20 번을 표시중입니다.

1 Conference A phase II study of gemcitabine, oxaliplatin, and erlotinib (GEMOX-T) combination chemotherapy in previously untreated patients with locally advanced unresectable or metastatic pancreatic cancer 김한조 ; 이상철 ; 배상병 ; et al 2014
2 Conference A phase II trial of weekly docetaxel for second-line treatment of urothelial carcinoma 이상철 2013
3 Conference A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer 김한조 ; 이상철 ; 배상병 ; et al 2018
4 Conference A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746) 김한조 2019
5 Conference A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial 김한조 2024
6 Conference Antiemetic effectiveness of palonosetron and first-generation serotonin inhibitors for high emetic risk chemotherapy in the post-aprepitant era 김한조 ; 이상철 ; 배상병 ; et al 2012
7 Conference Attenuated FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for the Koreans (Asian population) with gemcitabine-resistant or –refractory advanced pancreatic cancer 이상철 ; 이규택 ; 배상병 ; et al 2016
8 Conference Comprehensive analysis of mutation and expression based pathways in head and neck squamous cell carcinoma 이상철 2018
9 Conference Defensin-alpha 6 (DEFA6) as a protumorigenic function in vitro and prognostic marker in colorectal cancer 김한조 ; 안태성 ; 전섭 ; et al 2016
10 Conference Division of elderly patients in colorectal cancer: Korean national health insurance big data analysis 이상철 ; 배상병 2017
11 Conference Effect of dose escalation with single opioid, fentanyl matrix, for current cancer pain management: Multicenter, prospective, observational study 이규택 2012
12 Conference Hidden advertisements included in cancer information posts: Insights from social listening 이상철 2024
13 Conference In vitro functional study of Ang 2 in colorectal cancer cell line and the significance of Ang 2 expression in colorectal cancer patients 백무준 ; 김창진 ; 김한조 ; et al 2014
14 Conference In vitro functional study of novel oncogene serine protease 33 (PRSS33) and the clinical significance of PRSS33 expression in colorectal cancer patients 김한조 ; 안태성 ; 전섭 ; et al 2016
15 Conference Modified FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for gemcitabine-resistant or -refractory advanced pancreatic cancer 이상철 ; 이규택 ; 배상병 ; et al 2015
16 Conference Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3) 이상철 2021
17 Conference Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer 이규택 ; 배상병 ; 김한조 2014
18 Conference Nationwide real-world practice pattern and clinical data of palbociclib in patients with HR(+), HER2(-) metastatic breast cancer (KCSG BR21-15) 김한조 2024
19 Conference Overexpression of nuclear karyopherin alpha2 correlates with poor prognosis in patients with colorectal cancer 백무준 ; 김창진 ; 김한조 ; et al 2014
20 Conference PEARLY: A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo)adjuvant therapy in patients with early triple-negative breast cancer 김한조 2017

1 2 > >>

OAK SCHMC Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.